<DOC>
	<DOCNO>NCT01144507</DOCNO>
	<brief_summary>The specific aim study : 1 . To determine sonographic finding predict risk progression liver disease cirrhosis compare cystic fibrosis subject heterogeneous echogenicity pattern ultrasound normal echogenicity pattern ultrasound 2 . To develop database biorepository serum , plasma , urine DNA aid investigation ascertain mechanism , consequence , genetic risk factor biomarkers development cirrhosis 3 . To determine difference health relate quality life , pulmonary nutritional status child cystic fibrosis heterogeneous echo pattern ultrasound compare normal echo pattern ultrasound 4 . To determine Doppler velocity measurement hepatic splenic vessel predict increase risk development cirrhosis . 5 . To determine cirrhosis ultrasound progress portal hypertension study period 6 . To determine homogeneous liver progress either cirrhosis heterogeneous liver .</brief_summary>
	<brief_title>Prediction Ultrasound Risk Hepatic Cirrhosis Cystic Fibrosis</brief_title>
	<detailed_description>For subject longitudinal follow , study : 1 . Collect detailed clinical demographic information subject enrollment follow , 2 . Obtain store image data subject entry follow , 3 . Obtain store serum , plasma urine sample subject entry ( match ) follow , 4 . Obtain store DNA subject , 5 . Obtain store DNA biological parent , 6 . Obtain store quality life data subject parent enrollment follow</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Children age 3 12 year age time enrollment diagnose Cystic Fibrosis pancreatic insufficiency Enrolled CFF registry study Toronto CF Registry CF define sweat chloride &gt; 60 mEq/L one occasion ( use value CF registry ) two diseasecausing mutation CFTR evidence end organ involvement . Pancreatic insufficient define one following : CFTR Mutation associate pancreatic insufficiency Fecal elastase &lt; 100 mcg/gm ( time ) 72 hour fecal fat coefficient fat absorption &lt; 85 % ( time ) Known cirrhosis Presence Burkholderia cepacia Short bowel syndrome define full enteral feed 3 month age Presence serious disease preclude participation study ( This would include patient known cause chronic liver disease ) If opinion Investigator study best interest patient Inability comply longitudinal followup describe Failure family sign inform consent document HIPAA medical record release form</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Pancreatic insufficiency</keyword>
</DOC>